Estimate Recalculated Sep 11, 2024 12:43AM EST
Jonathan Schechter does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Atrinsic, Inc., Synaptogenix, Inc., WPCS INTERNATIONAL INC, Neurotrope, Inc., PharmaCyte Biotech, Inc., and Oblong, Inc..
Jonathan Schechter's CIK is 0001619259
2020 was Jonathan Schechter's most active year for acquiring shares with 6 total transactions. Jonathan Schechter's most active month to acquire stocks was the month of March. 2020 was Jonathan Schechter's most active year for disposing of shares, totalling 7 transactions. Jonathan Schechter's most active month to dispose stocks was the month of November. 2020 saw Jonathan Schechter paying a total of $79,442.50 for 165,000 shares, this is the most they've acquired in one year. In 2022 Jonathan Schechter cashed out on 20,250 shares for a total of $23,730.97, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!